Pluri Subsidiary Coffeesai Partners with Mexico’s INCAFECH to Advance Cell-Based Coffee Manufacturing

Pluri Inc. (NASDAQ:PLUR) is one of the best long term penny stocks with huge upside potential. On October 8, Pluri announced that its wholly-owned subsidiary, Coffeesai Ltd., had signed a collaboration agreement with the Instituto del Café de Chiapas/INCAFECH, a public body of the State of Chiapas, Mexico. The purpose of this state-backed collaboration is to advance cell-based coffee manufacturing in Mexico, positioning Chiapas, the country’s leading coffee-growing region, as a hub for innovation.

Coffeesai develops sustainable cell-based coffee products, using Pluri’s proprietary 3D cell expansion platform and two decades of expertise to create solutions. The partnership outlines a multi-phase, capital-light roadmap to de-risk commercialization.

Pluri Subsidiary Coffeesai Partners with Mexico's INCAFECH to Advance Cell-Based Coffee Manufacturing.

This effort is designed to create shareholder value for Plurithrough potential non-dilutive revenues from License and Technology Transfer, as well as recurring revenue streams via Royalty-bearing models, joint ventures, and potential sales tied to large-scale production.

Pluri Inc. (NASDAQ:PLUR) is a biotechnology company that researches, develops, and manufactures cell-based products, cell therapeutics, and related technologies for various industries.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.